SHINKEI Therapeutics Email Formats

Pharmaceutical Manufacturing • Plainsboro, New Jersey, United States • 1-10 Employees

Key Contact at SHINKEI Therapeutics

Mitch Guss

Vice President and General Counsel

Company overview

Headquarters	303a College Rd E, Princeton, New Jersey 08540, US
Phone number	+18555744653
Website	shinkeitherapeutics.com
NAICS	3254
SIC	283
Keywords	Neurology, Neurological Disorders, Traumatic Brain Injury, Drug Development, Drug Delivery, CNS, Movement Disorders, Pharmaceutical Development, 505(B)(2), Huntington'S Disease, Pharmaceutical Innovation, Pseudobulbar Affect
Founded	2017
Employees	1-10
Socials

About SHINKEI Therapeutics

SHINKEI is a clinical stage CNS (Central Nervous System) disorders focused pharmaceutical company using the 505(b)2 regulatory strategy to repurpose existing pharmaceutical products for faster and better patient outcome. We have a diversified and robust product development pipeline focus on improving a drug’s administration such that it allows use in indications not previously possible, enhances the convenience, improves compliance, and/or ameliorates the side-effects profile for patients SHINKEI was co-founded by Suresh Borsadia and GP Singh, industry veterans, having the mix of commercial and scientific backgrounds. They are supported by a nimble and efficient team of professionals, advisors and consultants.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

SHINKEI Therapeutics has never raised funding before.

SHINKEI Therapeutics Tech Stack

Discover the technologies and tools that power SHINKEI Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

LiteSpeed

Web servers

GoDaddy

Hosting

PHP

Programming languages

HTTP/3

Miscellaneous

Hostinger

Hosting

OWL Carousel

JavaScript libraries

Google Font API

Font scripts

Frequently asked questions

SHINKEI Therapeutics is located in Plainsboro, New Jersey, US.

You can reach SHINKEI Therapeutics at +18555744653.

SHINKEI Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

SHINKEI Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at SHINKEI Therapeutics

Mitch Guss

Vice President and General Counsel

4.8

40,000 users